Skip to content

Development of Telenursing for Diabetes Self-Management Education and Support (DSMES) among patients with T2DM in Thailand : A Randomized Controlled Trial

Development of Telenursing for Diabetes Self-Management Education and Support (DSMES) among patients with T2DM in Thailand : A Randomized Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260215010
Enrollment
128
Registered
2026-02-15
Start date
2026-02-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus, uncontrolled diabetes Diabetes Mellitus, Type 2

Interventions

Participants will receive 12 weeks DSMES program. The program begins with a one day onsite education session based on the AADE7 Self Care Behaviors framework. Participants will be instructed to record
Experimental Behavioral,No Intervention No treatment
Tele-nursing DSMES,Usual care

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. People with T2DM 2. Adults (age 20-64) and older adults (65 and above) 3. Uncontrolled diabetes, as determined by physician based on the diagnostic criteria of HbA1C more than 7% 4. Can read and write 5. Own a smartphone 6. Having internet connectivity 7. Able to receive a video call or with assistance from a caregiver

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. insulin-dependent patients 2. cognitive or mobility impairments , as assessed by the Thai Mental State Examination (TMSE). A TMSE score below 24 was considered indicative of cognitive impairment. 3. requiring special nursing care, such as patients with severe diabetic complications or those who are bedridden. 4. previous extensive DSMES exposure

Design outcomes

Primary

MeasureTime frame
Feasibility outcomes 12 weeks Participation rate, completion rate, and adherence level, were analyzed using descriptive statistics under the per-protocol (PP) approach

Secondary

MeasureTime frame
HbA1C baseline, 12 weeks measured using standard laboratory methods obtained from medical records,Body Mass Index baseline, 12 weeks Body weight (kg) and height (cm) will be measured using standard calibrated equipment, and body mass index (BMI) will be calculated as weight in kilograms divided by height in meters squared (kg/m2),Knowledge of diabetes baseline, 6 weeks, 12 weeks using the Thai version of Diabetes Knowledge Scale (DIAKS),Positive Coping behavior baseline, 6 weeks, 12 weeks using the Short Thai Stress Test (ST-5),A self-care behavior baseline, 6 weeks, 12 weeks using the Thai Diabetes Self-Management Questionnaire-Revised (T-DSMQ-R),Quality of life baseline, 6 weeks, 12 weeks using the Thai version of the Audit of Diabetes- Dependent Quality of Life (ADDQoL19),Health care costs 12 weeks include direct medical costs and non-medical costs through a detailed review of medical and financial records for each participant.,All-cause mortality risk 12 weeks hospital refer or admissions, and mortality data from hospital records,frequency of acute care use 12 weeks emergency visits from hospital records,Fasting blood glucose baseline, 12 weeks measured using standard laboratory methods obtained from medical records,Blood pressure baseline, 12 weeks measured using a standard blood pressure monitoring device and obtained from health assessment records

Countries

Thailand

Contacts

Public ContactRamida Subpaiboonkit

Chiang Mai University, Taipei medical university

ramida.s@cmu.ac.th0856145443

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026